TOMM40 poly-T repeat lengths, age of onset and psychosis risk in Alzheimer disease

Neurobiology of Aging

Volumn 32, Issue 12, 2011, Pages 2328.e1-2328.e9

  Chu, Su Hee ^a   Roeder, Kathryn ^a   Ferrell, Robert E ^b   Devlin, Bernie ^c   DeMichele Sweet, Mary Ann A ^c   Kamboh, M Ilyas ^b,c   Lopez, Oscar L ^c   Sweet, Robert A ^c,d  

^a CARNEGIE MELLON UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Apolipoprotein E (APOE) 4; Late onset Alzheimer disease (LOAD); Psychosis; TOMM40; Variable length poly T repeat sequence

Indexed keywords

APOLIPOPROTEIN E4; DNA; THYMINE;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; DNA SEQUENCE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE PHENOTYPE CORRELATION; HERITABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE REPEAT; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSYCHOSIS; TOMM40 GENE;

EID: 80053627404     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2011.06.016     Document Type: Article

References (19)

1. Bacanu S.A., Devlin B., Chowdari K.V., DeKosky S.T., Nimgaonkar V.L., Sweet R.A. Heritability of psychosis in Alzheimer disease. Am. J. Geriatr. Psychiatry 2005, 13:624-627.
2. Bekris L.M., Galloway N.M., Montine T.J., Schellenberg G.D., Yu C.E. APOE mRNA and protein expression in postmortem brain are modulated by an extended haplotype structure. Am. J. Med. Genet. B Neuropsychiatr. Genet 2010, 153B:409-417.
3. DeMichele-Sweet M.A., Klei L., Devlin B., Ferrell R.E., Weamer E.A., Emanuel J.E., Lopez O.L., Sweet R.A. No association of psychosis in Alzheimer disease with neurodegenerative pathway genes. Neurobiol. Aging 2011, 32:555.e9-555.e11.
4. DeMichele-Sweet M.A., Lopez O.L., Sweet R.A. Psychosis in Alzheimer disease in the National Alzheimer Disease Coordinating Center Uniform Data Set: Clinical correlates and association with apoliprotien E. Int. J. Alzheimers Dis 2011, 2011. 926597.
5. DeMichele-Sweet M.A., Sweet R.A. Genetics of psychosis in Alzheimer's disease: a review. J. Alzheimers Dis 2010, 19:761-780.
6. Emanuel J.E., Lopez O.L., Houck P.R., Becker J.T., Weamer E.A., Demichele-Sweet M.A., Kuller L., Sweet R.A. Trajectory of cognitive decline as a predictor of psychosis in early Alzheimer disease in the cardiovascular health study. Am. J. Geriatr. Psychiatry 2011, 19:160-168.
7. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., van Duijn C.M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997, 278:1349-1356.
8. Ferri C.P., Prince M., Brayne C., Brodaty H., Fratiglioni L., Ganguli M., Hall K., Hasegawa K., Hendrie H., Huang Y., Jorm A., Mathers C., Menezes P.R., Rimmer E., Scazufca M. Global prevalence of dementia: a Delphi consensus study. Lancet 2005, 366:2112-2117. Alzheimer's Disease International.
9. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res 1975, 12:189-198.
10. Gatz M., Pedersen N.L., Berg S., Johansson B., Johansson K., Mortimer J.A., Posner S.F., Viitanen M., Winblad B., Ahlbom A. Heritability for Alzheimer's disease: the study of dementia in Swedish twins. J. Gerontol. A Biol. Sci. Med. Sci 1997, 52:M117-M125.
11. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984, 34:939-944.
12. Pedersen N.L., Posner S.F., Gatz M. Multiple-threshold models for genetic influences on age of onset for Alzheimer disease: findings in Swedish twins. Am. J. Med. Genet 2001, 105:724-728.
13. Reitz C., Mayeux R. Endophenotypes in normal brain morphology and Alzheimer's disease: a review. Neuroscience 2009, 164:174-190.
14. Ropacki S.A., Jeste D.V. Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003. Am. J. Psychiatry 2005, 162:2022-2030.
15. Roses A.D., Lutz M.W., Amrine-Madsen H., Saunders A.M., Crenshaw D.G., Sundseth S.S., Huentelman M.J., Welsh-Bohmer K.A., Reiman E.M. A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease. Pharmacogenomics J 2010, 10:375-384.
16. Sweet R.A., Bennett D.A., Graff-Radford N.R., Mayeux R. Assessment and familial aggregation of psychosis in Alzheimer's disease from the National Institute on Aging Late Onset Alzheimer's Disease Family Study. Brain 2010, 133:1155-1162. National Institute on Aging Late-Onset Alzheimer's Disease Family Study Group.
17. Sweet R.A., Nimgaonkar V.L., Devlin B., Jeste D.V. Psychotic symptoms in Alzheimer disease: evidence for a distinct phenotype. Mol. Psychiatry 2003, 8:383-392.
18. Tariot P.N., Mack J.L., Patterson M.B., Edland S.D., Weiner M.F., Fillenbaum G., Blazina L., Teri L., Rubin E., Mortimer J.A., Stern Y. The behavior rating scale for dementia of the Consortium to Establish a Registry for Alzheimer's Disease. Am. J. Psychiatry 1995, 152:1349-1357. Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease.
19. Yu C.E., Seltman H., Peskind E.R., Galloway N., Zhou P.X., Rosenthal E., Wijsman E.M., Tsuang D.W., Devlin B., Schellenberg G.D. Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association. Genomics 2007, 89:655-665.